| Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety (NCT06595953) | National Institute of Mental Health (NIMH) | 2024-12-04 |
| Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline (NCT06477185) | Makerere University | 2024-12-04 |
| Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML (NCT06679582) | Sutro Biopharma, Inc. | 2024-12-04 |
| Vedolizumab for the Treatment of Collagenous Gastritis (NCT06317220) | Massachusetts General Hospital | 2024-12-03 |
| A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia (NCT07421232) | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 2024-12-03 |
| HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer (NCT06587061) | Ruijin Hospital | 2024-12-03 |
| Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC (NCT06699498) | The First Affiliated Hospital with Nanjing Medical University | 2024-12-03 |
| Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in Osteosarcoma (NCT06562673) | Shanghai 6th People's Hospital | 2024-12-03 |
| Meditation to Reduce Firefighter Distress (NCT06518616) | University of Arizona | 2024-12-03 |
| Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy (NCT06721520) | The Cleveland Clinic | 2024-12-03 |
| Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression (NCT06180356) | MedSIR | 2024-12-03 |
| A Safety and Efficacy of Intrathecally Administered ION283 in Patients With Lafora Disease (NCT06609889) | Berge Minassian | 2024-12-03 |
| Clinical Trial of AGB101 for Mild Cognitive Impairment (NCT05986721) | AgeneBio | 2024-12-03 |
| Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05) (NCT06832904) | First Affiliated Hospital of Zhejiang University | 2024-12-03 |
| Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma (NCT06567314) | M.D. Anderson Cancer Center | 2024-12-02 |
| Sintilimab in Combination with Chemotherapy ± Local Treatment for Om-G/GEJ (NCT06739161) | Jiangsu Cancer Institute & Hospital | 2024-12-02 |
| Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis (NCT06526104) | The University of Texas Health Science Center at San Antonio | 2024-12-02 |
| AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma (NCT05669339) | University of Florida | 2024-12-02 |
| Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial (NCT06580002) | University of California, Irvine | 2024-12-02 |
| A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease (NCT06717698) | Novo Nordisk A/S | 2024-12-02 |
| Tuberoplasty Versus Balloon Spacer (NCT06735170) | University of Minnesota | 2024-12-02 |
| Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels (NCT06496243) | NewAmsterdam Pharma | 2024-12-02 |
| Corticosteroids for Post-Extubation Dysphagia (NCT06670521) | University of Colorado, Denver | 2024-12-02 |
| High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI (NCT06924684) | Sheikh Zayed Federal Postgraduate Medical Institute | 2024-12-02 |
| Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer (NCT06528483) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2024-12-02 |
| Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (NCT06054776) | City of Hope Medical Center | 2024-12-02 |
| Phase I/II Randomized Clinical Trial of Allogeneic Adipose Tissue-derived Mesenchymal Stromal Cells Systemic Infusion in Severe Systemic Sclerosis (NCT06722105) | Assistance Publique - Hôpitaux de Paris | 2024-12-01 |
| A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors (NCT06724263) | Tasly Biopharmaceuticals Co., Ltd. | 2024-12-01 |
| JAK1 Inhibitor Ivarmacitinib Reversing Immunotherapy Resistance in TNBC (NCT06731153) | Fudan University | 2024-12-01 |
| A Clinical Study on Co-transplantation of Autologous Limbal Stem Cells and Corneal Stromal Stem Cells to Repair Corneal Injury (NCT06700655) | Zhongshan Ophthalmic Center, Sun Yat-sen University | 2024-12-01 |
| Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast Cancer (NCT06470672) | Fudan University | 2024-12-01 |
| Induction Immunotherapy Combined With Chemotherapy Followed by Concurrent Chemoradiotherap and Immunotherapy for Cervical Cancer (NCT07092696) | Tianjin Medical University Cancer Institute and Hospital | 2024-12-01 |
| A Clinical Study Based on FAPI-PET/CT Technology to Predict Pathological Complete Response After Neoadjuvant Chemoradiotherapy for MSS Rectal Cancer (NCT06608537) | Sun Yat-sen University | 2024-12-01 |
| Adrenaline Nasal Pack vs Xylometazoline Nasal Drops During Nasotracheal Intubation (NCT06801522) | Shaheed Mohtarma Benazir Bhutto Institue of Trauma | 2024-12-01 |
| Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers (NCT06746441) | Khyber Medical University Peshawar | 2024-12-01 |
| The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors (NCT06775080) | Huashan Hospital | 2024-12-01 |
| BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma (NCT05538988) | AHS Cancer Control Alberta | 2024-12-01 |
| Supportive Psychotherapy as Adjunct to Risperidone for Cognitive Function and Inflammation in Schizophrenia (NCT07477301) | Hasanuddin University | 2024-12-01 |
| Auto-HSCT-Supported Dose-Dense Chemotherapy with Adebrelimab As First-Line Treatment for ES-SCLC (NCT06597513) | Zhou Chengzhi | 2024-12-01 |
| Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases (NCT06683703) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2024-12-01 |
| An Open Label Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacologic Properties of High Dose Ambroxol Hydrochloride in Adult (≥ 18 Years of Age) Subjects With MPS III (NCT06614894) | Ozlem Goker-Alpan | 2024-12-01 |
| Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study (NCT06728852) | Li-kun Chen | 2024-12-01 |
| A Single-arm, Single-center Phase II Clinical Study on the Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection Combined With Fruquintinib Capsules in the Second-line Treatment of Patients With Advanced Gastric Cancer (NCT06706895) | Shanghai Zhongshan Hospital | 2024-12-01 |
| Rapid BAC Reduction with Nutraceutical Blend Study (NCT06722898) | Medical Life Care Planners, LLC | 2024-12-01 |
| SHR-1701 Combined with SHR2554 and BP102 for MCRC (NCT06679673) | Fudan University | 2024-12-01 |
| VHAG in Treating R/R T-ALL/LBL (NCT06742463) | First Affiliated Hospital of Zhejiang University | 2024-12-01 |
| Comparison Between Botox and Magnesium Sulfate Effect in Treatment of Myofascial Pain Trigger Points Within the Masseter Muscle (NCT06676475) | Misr University for Science and Technology | 2024-12-01 |
| MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients (NCT06308926) | MedRegen LLC | 2024-12-01 |
| Y-90 SIRT for Unresectable HCC Larger Than 7cm (NCT06707233) | Second Affiliated Hospital of Guangzhou Medical University | 2024-12-01 |
| Cerebrospinal Fluid Immune Microenvironment Mechanism in Anaplastic Lymphoma Kinase Positive Lung Cancer Patients (NCT06697990) | Tianjin Medical University Cancer Institute and Hospital | 2024-12-01 |
| A Phase II Study of SHR-4602 as Montherapy or in Combination With Other Anti-tumor Therapies in Advanced Solid Tumors (NCT06704828) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-12-01 |
| SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer (NCT06666166) | Yunpeng Liu | 2024-12-01 |
| Testing of a System for Remote Ischemic Conditioning in Cerebral Small Vessel Disease and Pre-hospital Stroke Care (NCT05967728) | University of Calgary | 2024-12-01 |
| Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants (NCT03605654) | Medeor Therapeutics, Inc. | 2024-12-01 |
| Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis (NCT06510283) | Beijing Tongren Hospital | 2024-12-01 |
| MAGIK for Femoral/Tibial Shaft Fractures (NCT05627479) | NYU Langone Health | 2024-12-01 |
| The Sub-Sero Study (NCT03994965) | Bjorn H. Ebdrup | 2024-12-01 |
| Sasanlimab As Maintenance Treatment Based on Clinical Response to Neoadjuvant Treatment in Molecularly Categorized Muscle Invasive Bladder Cancer Patients (NCT06623162) | Fundación de investigación HM | 2024-12-01 |
| Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer (NCT06670300) | YongZhang | 2024-12-01 |
| Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL (NCT06754267) | First Affiliated Hospital of Zhejiang University | 2024-12-01 |
| A Study of Jaktinib for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease. (NCT04971551) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2024-12-01 |
| A Study of MFA-370 in Patients with Metastatic Urothelial Cancer (NCT05390645) | Ectin Research AB | 2024-12-01 |
| Intra-arterial Chemotherapy Combined with Radiotherapy and Immunotherapy for HNSCC (NCT06725498) | Beijing Tongren Hospital | 2024-12-01 |
| Methylglyoxal (MGO) Lowering Cocktail to Reduce Appetite in Obese Individuals (NCT05083546) | University of California, San Francisco | 2024-12-01 |
| Pembrolizumab in Combination with Flutamide Treatment for Recurrence / Metastasis HNSCC (NCT06694350) | Zhejiang Provincial People's Hospital | 2024-12-01 |
| Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients (NCT06673628) | National Cancer Center, Japan | 2024-12-01 |
| A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer (NCT06513884) | Hookipa Biotech GmbH | 2024-12-01 |
| Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of Sepsis (NCT06626984) | Belfast Health and Social Care Trust | 2024-12-01 |
| Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome (NCT06723002) | University of Monastir | 2024-12-01 |
| Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL) (NCT06549335) | Ruijin Hospital | 2024-12-01 |
| Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT (NCT06693791) | Anhui Provincial Hospital | 2024-12-01 |
| Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7 (NCT06020755) | Peking Union Medical College Hospital | 2024-12-01 |
| Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD) (NCT05880524) | Ludwig-Maximilians - University of Munich | 2024-12-01 |
| Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDS (NCT05127122) | Direct Biologics, LLC | 2024-12-01 |
| Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney Transplants (NCT03606746) | Medeor Therapeutics, Inc. | 2024-12-01 |
| Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant (NCT06725121) | University Health Network, Toronto | 2024-12-01 |
| The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM (NCT06218524) | Southern Medical University, China | 2024-12-01 |
| ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT (NCT06646666) | Ruijin Hospital | 2024-12-01 |
| Clinical Study on the Safety, Efficacy and Pharmacokinetics of Telpegfilgrastim in Pediatric Cancer Patients with Chemotherapy (NCT06857292) | Sun Yat-sen University | 2024-12-01 |
| First-line Treatment of Advanced/unresectable DDLPS (NCT06694324) | Fudan University | 2024-12-01 |
| ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC (NCT06426511) | Sun Yat-sen University | 2024-12-01 |
| TCR Alpha/Beta and CD19-deplete Haplo-HSCT (NCT05288595) | University of Colorado, Denver | 2024-12-01 |
| A Prospective, Single-Center Study Evaluating the Efficacy and Safety of Glofitamab Combined With Orelabrutinib and Bortezomib in Patients With High-Risk Mantle Cell Lymphoma (NCT06656221) | Ruijin Hospital | 2024-12-01 |
| Re-induction of a Systemic Immune Response in Metastatic or Locally Recurrent Lung Cancer (NCT06024941) | Maastricht Radiation Oncology | 2024-12-01 |
| A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1) (NCT05859217) | Jun Zhang, MD, PhD | 2024-12-01 |
| PEX010-Assisted Therapy for Opioid Use Disorder (OUD): a Feasibility Study (NCT06608459) | Filament Health Corp. | 2024-12-01 |
| Evaluation of Patients With Refractory Dermatomyositis Using [18F] FAPI-74 PET/MRI Imaging (NCT06568783) | Farshad Moradi | 2024-12-01 |
| A Study for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions (NCT06731829) | Jiangsu HengRui Medicine Co., Ltd. | 2024-12-01 |
| Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice: (NCT06322238) | Mayo Clinic | 2024-12-01 |
| Dapagliflozin as Prophylaxis for Glucocorticoid-Induced Hyperglycemia (NCT06748105) | Lauro Fabián Amador Medina | 2024-12-01 |
| Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS (NCT06598202) | Xuanwu Hospital, Beijing | 2024-12-01 |
| Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC (NCT06497530) | Guangzhou Institute of Respiratory Disease | 2024-12-01 |
| Cnidium Monnieri Detoxification Formula for Persistent High-risk Human Papillomavirus Infection of Cervix. (NCT06705322) | Fudan University | 2024-12-01 |
| Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide (NCT06387199) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2024-12-01 |
| CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) (NCT05854966) | Wake Forest University Health Sciences | 2024-12-01 |
| A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC (NCT06584071) | Biotheus Inc. | 2024-12-01 |
| Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors (NCT06730581) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2024-12-01 |
| Efficacy and Safety of Neoadjuvant Sintilimab Plus FLOT Versus Sintilimab Plus SOX Phase II Clinical Trial for Patients With Locally Advanced Gastric Cancer (NCT06459921) | Xijing Hospital | 2024-12-01 |
| Intracerebral Autologous Stem Cell Therapy for Chronic Stroke Patients (NCT06752720) | Hokkaido University Hospital | 2024-12-01 |
| Effectiveness of Adding Morphine to Intraosseous Vancomycin for Pain Control in Total Knee Arthroplasty (NCT06716749) | Carilion Clinic | 2024-12-01 |